Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.77 CAD | -0.86% | -1.54% | +11.18% |
Mar. 22 | Knight Therapeutics Price Target Raised to $7 at RBC | MT |
Mar. 21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.18% | 431M | |
+6.04% | 71.48B | |
+11.94% | 9.18B | |
-16.33% | 4.79B | |
+26.98% | 3.98B | |
+6.40% | 3.97B | |
+28.78% | 2.56B | |
-26.55% | 2.29B | |
-25.02% | 2.23B | |
+5.82% | 1.92B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Knight Therapeutics Brief: Reports Q4 Net Loss $8,3 Million Vs Income of Near 8.233 Million a Year Earlier